Abaxis signs distribution deal for Piccolo chemistry analyzer, human reagent rotors

By E. Janene Geiss

Philadelphia, June 29 - Abaxis, Inc. said Thursday that the company has entered into a formal distribution agreement with Henry Schein, Inc., the largest provider of health care products and services to office-based practitioners in the combined North American and European markets.

Under the agreement, Henry Schein's medical group will sell and distribute the complete line of Abaxis' human reagent rotors and the Piccolo chemistry analyzer within the U.S. medical market, according to a company news release.

Henry Schein's medical sales force includes about 550 representatives and an in-house marketing and sales group.

Abaxis is a Union City, Calif., medical products company that makes portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.